Glossaries

Connect with us

Invega Hafyera
paliperidone
Company
Janssen
Product website
FDA Label

Indications

  • Treatment of schizophrenia in adults after they have been adequately treated with: • A once-a-month paliperidone palmitate extended-release injectable suspension (e.g., INVEGA SUSTENNA) for at least four months or • An every-three-month paliperidone palmitate extended-release injectable suspension (e.g., INVEGA TRINZA) for at least one three-month cycle.

Companies

Molecular entities

Daily Posts

CNS Drug: #CNSDOD
Notable Person: #BHCPOD
Phobia: #BNphobia
Term: #BHCTOD

National Conference #Hashtags

8/29-31 NAADAC
#NAADAC2026